Molecular and clinical aspects of potential neurotoxicity induced by new psychoactive stimulants and psychedelics
Open Access
- 1 September 2021
- journal article
- review article
- Published by Elsevier in Experimental Neurology
- Vol. 343, 113778
Abstract
No abstract availableKeywords
Funding Information
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (P2BSP3_191740, P400PM_191032)
- Bundesamt für Gesundheit (16.921318)
This publication has 236 references indexed in Scilit:
- Psychedelics and Mental Health: A Population StudyPLOS ONE, 2013
- Differential effects of cathinone compounds andMDMAon body temperature in the rat, and pharmacological characterization of mephedrone‐induced hypothermiaBritish Journal of Pharmacology, 2013
- Mephedrone in Adolescent Rats: Residual Memory Impairment and Acute but Not Lasting 5-HT DepletionPLOS ONE, 2012
- The Designer Methcathinone Analogs, Mephedrone and Methylone, are Substrates for Monoamine Transporters in Brain TissueNeuropsychopharmacology, 2011
- Pro‐oxidant effects of Ecstasy and its metabolites in mouse brain synaptosomesBritish Journal of Pharmacology, 2011
- Clinical characteristics of mephedrone toxicity reported to the UK National Poisons Information ServiceEmergency Medicine Journal, 2010
- The role of monoamines in the changes in body temperature induced by 3,4‐methylenedioxymethamphetamine (MDMA, ecstasy) and its derivativesBritish Journal of Pharmacology, 2010
- Products of Oxidative Stress Inhibit Aldehyde Oxidation and Reduction Pathways in Dopamine Catabolism Yielding Elevated Levels of a Reactive IntermediateChemical Research in Toxicology, 2009
- Patterns of benzylpiperazine/trifluoromethylphenylpiperazine party pill use and adverse effects in a population sample in New ZealandDrug and Alcohol Review, 2008
- Oxidative stress and neurodegeneration: where are we now?Journal of Neurochemistry, 2006